|
Name |
Methyl arachidate
|
Molecular Formula | C21H42O2 | |
IUPAC Name* |
methyl icosanoate
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C21H42O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(22)23-2/h3-20H2,1-2H3
|
|
InChIKey |
QGBRLVONZXHAKJ-UHFFFAOYSA-N
|
|
Synonyms |
Methyl arachidate; 1120-28-1; Methyl icosanoate; Arachidic acid methyl ester; Eicosanoic acid, methyl ester; METHYL EICOSANOATE; Methyl arachisate; MFCD00009014; Eicosanoic acid-methyl ester; Eicosanoic Acid Methyl Ester; 0ZH75194U0; Eicosanoic acid-methyl ester 10 microg/mL in Acetonitrile; MethylArachidate; methyl arachate; Methyl aracidate; EINECS 214-304-8; Methyl icosanoate #; Icosanoic acid methyl; Kemester 2050; AI3-36455; arachic acid methyl ester; Icosanoic Acid Methyl Ester; SCHEMBL586921; DTXSID2061515; UNII-0ZH75194U0; CHEBI:143582; ZINC70455484; Methyl arachidate, analytical standard; N-EICOSANOIC ACID METHYL ESTER; AKOS015904080; CS-W004291; HY-W004291; AS-49345; Eicosanoic acid methyl ester (FAME MIX); SY048228; DB-041032; Methyl arachidate, >=99% (capillary GC); A0900; FT-0622455; H10876; A894661; J-002693; Q63398929; 4B020CF8-8307-42EE-AE7F-95190AB03DFA
|
|
CAS | 1120-28-1 | |
PubChem CID | 14259 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 326.6 | ALogp: | 10.1 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 19 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 23 | QED Weighted: | 0.197 |
Caco-2 Permeability: | -4.964 | MDCK Permeability: | 0.00001120 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.955 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.109 | Plasma Protein Binding (PPB): | 97.17% |
Volume Distribution (VD): | 3.112 | Fu: | 1.31% |
CYP1A2-inhibitor: | 0.173 | CYP1A2-substrate: | 0.183 |
CYP2C19-inhibitor: | 0.299 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.103 | CYP2C9-substrate: | 0.955 |
CYP2D6-inhibitor: | 0.268 | CYP2D6-substrate: | 0.041 |
CYP3A4-inhibitor: | 0.29 | CYP3A4-substrate: | 0.04 |
Clearance (CL): | 4.655 | Half-life (T1/2): | 0.143 |
hERG Blockers: | 0.366 | Human Hepatotoxicity (H-HT): | 0.023 |
Drug-inuced Liver Injury (DILI): | 0.426 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.018 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.964 | Carcinogencity: | 0.042 |
Eye Corrosion: | 0.948 | Eye Irritation: | 0.949 |
Respiratory Toxicity: | 0.893 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000497 | 0.955 | D00AOJ | 0.663 | ||||
ENC000464 | 0.917 | D07ILQ | 0.615 | ||||
ENC000280 | 0.909 | D00FGR | 0.533 | ||||
ENC000496 | 0.864 | D0Z5SM | 0.500 | ||||
ENC000724 | 0.846 | D00STJ | 0.475 | ||||
ENC000271 | 0.818 | D0O1PH | 0.467 | ||||
ENC000357 | 0.817 | D05ATI | 0.430 | ||||
ENC001304 | 0.795 | D00MLW | 0.402 | ||||
ENC000258 | 0.792 | D0T9TJ | 0.378 | ||||
ENC000553 | 0.786 | D0P1RL | 0.343 |